| Description | Rostafuroxin (PST 2238) has been used in trials studying the treatment of Essential Hypertension. |
| Target activity | K+-ATPase:1.5 nM, Na+-ATPase:1.5 nM |
| Synonyms | PST 2238 |
| molecular weight | 374.51 |
| Molecular formula | C23H34O4 |
| CAS | 156722-18-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 50 mg/mL (133.5 mM) |
| References | 1. Wenceslau CF, Rossoni LV. J Hypertens. 2014 Mar; 32(3): 542-54. 2. Gan H, Qi M, Chan C, et al. Digitoxin inhibits HeLa cell growth through the induction of G2/M cell cycle arrest and apoptosis in vitro and in vivo[J]. International journal of oncology . 2020. |
| Citations | 1. Gan H, Qi M, Chan C, et al. Digitoxin inhibits HeLa cell growth through the induction of G2/M cell cycle arrest and apoptosis in vitro and in vivo. International journal of oncology. 2020 |